Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach

Autor: Antonio Corsello, Daniela Pugliese, Fiammetta Bracci, Daniela Knafelz, Bronislava Papadatou, Marina Aloi, Salvatore Cucchiara, Luisa Guidi, Antonio Gasbarrini, Alessandro Armuzzi

Publikováno v: Italian Journal of Pediatrics, Vol 47, Iss 1, Pp 1-8 (2021)

Abstract Background Transition from pediatric to adult care of patients affected by Inflammatory Bowel Disease (IBD) is a critical step that needs specific care and multidisciplinary involvement. The aim of our study was to evaluate the outcome of th

Externí odkaz: https://doaj.org/article/374a2b25744442318e8179f8fd088816

Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry

Autor: Patrizia Alvisi, Flavio Labriola, Luca Scarallo, Paolo Gandullia, Daniela Knafelz, Matteo Bramuzzo, Giovanna Zuin, Maria Rosa Pastore, Maria Teresa Illiceto, Erasmo Miele, Francesco Graziano, Claudio Romano, Daniela Bartoletti, Salvatore Oliva, Serena Arrigo, Fiammetta Bracci, Sara Renzo, Anna Agrusti, Marina Aloi, Paolo Lionetti, Salvatore Accomando, Claudia Banzato, Graziano Barera, Marco Brunero, Pier Luigi Calvo, Angelo Campanozzi, Mara Cananzi, Mara Corpino, Rita Cozzali, Gianluigi De Angelis, Costantino De Giacomo, Dario Dilillo, Enrico Felici, Simona Gatti, Valentina Motta, Lorenzo Norsa, Paolo Maria Pavanello, Andrea Pession, Silvia Provera, Alberto Ravelli, Antonio Maria Ricci, Silvia Salvatore, Caterina Strisciuglio

Introduction: The present study aimed at evaluating Italian epidemiological trends of pediatric inflammatory bowel diseases (IBD) over the period 2009–2018. Materials and methods: Data from 1969 patients enrolled in the Italian Society of Pediatric

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39a9f322cf85d685203995a255c1f9c7
http://hdl.handle.net/10447/540778

Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN

Autor: Harland S. Winter, Jorge Amil Dias, Claudio Romano, Malgorzata Sladek, Arnold G. Vulto, Victorien M. Wolters, Paolo Lionetti, Amit Assa, Gábor Veres, Almuthe C. Hauer, Caterina Strisciuglio, Lissy de Ridder, Richard K. Russell, Daniela Knafelz, Jiri Bronsky, Nadeem A. Afzal

Publikováno v: Journal of Pediatric Gastroenterology and Nutrition, 68(1), 144-153. Lippincott Williams & Wilkins
Journal of Pediatric Gastroenterology and Nutrition, 68(1), 144. Lippincott Williams and Wilkins

Biologic therapies have changed the outcome of both adult and pediatric patients with Inflammatory Bowel Disease (IBD). In September 2013, the first biosimilar of infliximab was introduced into the pharmaceutical market. In 2015, a first position pap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b212099309df36850facd11b2c4f118
https://doi.org/10.1097/mpg.0000000000002141

Etiology and management of pediatric intestinal failure: Focus on the non-digestive causes

Autor: Giacomo Calvitti, Lorenzo Iughetti, Teresa Capriati, Giulia Bolasco, Antonella Diamanti, Diego Martinelli, Arturo Pujia, Daniela Knafelz, Emma Santariga, Giuseppe Maggiore

Publikováno v: Nutrients
Nutrients, Vol 13, Iss 786, p 786 (2021)

Background: Intestinal failure (IF) is defined as reduction in functioning gut mass below the minimal amount necessary for adequate digestion and absorption. In most cases, IF results from intrinsic diseases of the gastrointestinal tract (digestive I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f4989a1deed048a70635ffaf3835b2d
https://hdl.handle.net/11380/1238472

Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry

Autor: Matteo Bramuzzo, Marina Aloi, Simona Gatti, Giulia D'Arcangelo, Dario Dilillo, Francesca Zucconi, Alberto Ravelli, Doriana Lacorte, M.T. Illiceto, Claudio Romano, Serena Arrigo, Salvatore Cucchiara, Daniela Knafelz, Patrizia Alvisi, Giovanna Zuin

Publikováno v: Journal of Pediatric Gastroenterology & Nutrition. 66:920-925

OBJECTIVES The aim of this study was to evaluate the effectiveness and safety of adalimumab (ADA) in children with ulcerative colitis (UC) previously treated with infliximab (IFX). METHODS Retrospective study including children with UC from a nationa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::314f73ef8604dbe6aaa9d37c7201c89d
https://doi.org/10.1097/mpg.0000000000001883